Terlipressin for Injection - Global and China Top Players Market Share and Ranking 2023
According to the research report, the global market for Terlipressin for Injection should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Terlipressin for Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Terlipressin for Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Internal Medicine Application grew percent to account for percent of the total market sales, and surgical application grew percent.
Terlipressin for injection is a synthetic polypeptide that is an analog of the hormone secreted by the posterior pituitary gland. After injection, its triglycyl group will be cleaved by enzymes in the body to slowly release active substances such as vasopressin, which can contract smooth muscles and last for 10 hours. Vasopressin mainly has two effects: one is the obvious vasoconstriction effect, thereby reducing the venous blood flow to the hepatic portal system, thereby lowering the portal blood pressure and having a hemostatic effect; Body, prevent excessive loss of water in urine, has anti-enuresis function. Terlipressin for injection lowers HVPG faster, stronger, and longer, and it is a drug for the treatment of complications of portal hypertension.
This report studies and analyses global Terlipressin for Injection status and future trends, helps the client to determine the Terlipressin for Injection market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Terlipressin for Injection, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Terlipressin for Injection market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Terlipressin for Injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Terlipressin for Injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Terlipressin for Injection key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Terlipressin for Injection key producing regions, capacity, production, and year over year growth
(6) Terlipressin for Injection industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Ferring Pharmaceuticals
Ranbaxy UK Ltd
TAJ LIFE SCIENCES
Mallinckrodt plc
EVER Pharma
Alliance Pharmaceuticals
Serum Institute of India Pvt. Ltd
Biovenice Criticure
Criticine Care
Integrated Laboratories Pvt Ltd
Hybio Pharmaceutical Co., Ltd
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
Hangzhou Ausia Biological Technology Company, Ltd
Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
Hainan General Sanyang Pharmaceutical Co., Ltd
Market segment by Type, covers
Lumps
Powder
Market segment by Application, can be divided into
Internal Medicine Application
surgical application
Intensive Care Unit (ICU) Applications
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Terlipressin for Injection product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Terlipressin for Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Terlipressin for Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Terlipressin for Injection, percent & CAGR, 2018-2029
Chapter 5: Terlipressin for Injection industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Terlipressin for Injection Definition
1.2 Global Terlipressin for Injection Market Size and Forecast
1.2.1 By Consumption Value, Global Terlipressin for Injection Market Size，2018-2029
1.2.2 By Sales Quantity, Global Terlipressin for Injection Market Size，2018-2029
1.2.3 Global Terlipressin for Injection Average Selling Price (ASP)，2018-2029
1.3 China Terlipressin for Injection Market Size and Forecast
1.3.1 By Consumption Value, China Terlipressin for Injection Market Size，2018-2029
1.3.2 By Sales Quantity, China Terlipressin for Injection Market Size，2018-2029
1.3.3 China Terlipressin for Injection Average Selling Price (ASP)， 2018-2029
1.4 Share of China Terlipressin for Injection Market with Respect to the Global Market
1.4.1 By Consumption Value, China Terlipressin for Injection Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Terlipressin for Injection Market Share in Global, 2018-2029
1.4.3 Terlipressin for Injection Market Size: China VS Global, 2018-2029
1.5 Terlipressin for Injection Market Dynamics
1.5.1 Terlipressin for Injection Market Drivers
1.5.2 Terlipressin for Injection Market Restraints
1.5.3 Terlipressin for Injection Industry Trends
1.5.4 Terlipressin for Injection Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Terlipressin for Injection, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Terlipressin for Injection, Global Market Share by Company, 2018-2023
2.3 Terlipressin for Injection Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Terlipressin for Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Terlipressin for Injection Concentration Ratio
2.6 Global Terlipressin for Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Terlipressin for Injection Manufacturers Product Type
2.8 Head Office and Terlipressin for Injection Production Site of Key Manufacturer
2.9 Terlipressin for Injection Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Terlipressin for Injection, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Terlipressin for Injection, China Market Share by Company, 2018-2023
3.3 China Terlipressin for Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Terlipressin for Injection Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Terlipressin for Injection Capacity by Region
4.3 Global Terlipressin for Injection Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Terlipressin for Injection Production by Region, 2018-2029
4.5 Global Terlipressin for Injection Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Terlipressin for Injection Industry Chain
5.2 Terlipressin for Injection Upstream Analysis
5.2.1 Terlipressin for Injection Core Raw Materials
5.2.2 Main Manufacturers of Terlipressin for Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Terlipressin for Injection Production Mode
5.6 Terlipressin for Injection Procurement Model
5.7 Terlipressin for Injection Industry Sales Model and Sales Channels
5.7.1 Terlipressin for Injection Sales Model
5.7.2 Terlipressin for Injection Typical Distributors
6 Sights by Type
6.1 Terlipressin for Injection Classification
6.1.1 Lumps
6.1.2 Powder
6.2 By Type, Global Terlipressin for Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Terlipressin for Injection Consumption Value, 2018-2029
6.4 By Type, Global Terlipressin for Injection Sales Quantity, 2018-2029
6.5 By Type, Global Terlipressin for Injection Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Terlipressin for Injection Segment by Application
7.1.1 Internal Medicine Application
7.1.2 surgical application
7.1.3 Intensive Care Unit (ICU) Applications
7.2 By Application, Global Terlipressin for Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Terlipressin for Injection Consumption Value, 2018-2029
7.4 By Application, Global Terlipressin for Injection Sales Quantity, 2018-2029
7.5 By Application, Global Terlipressin for Injection Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Terlipressin for Injection Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Terlipressin for Injection Consumption Value, 2018-2029
8.3 By Region, Global Terlipressin for Injection Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Terlipressin for Injection & Forecasts, 2018-2029
8.4.2 By Country, North America Terlipressin for Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Terlipressin for Injection Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Terlipressin for Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Terlipressin for Injection Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Terlipressin for Injection Market Size Market Share
8.7 South America
8.7.1 South America Terlipressin for Injection Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Terlipressin for Injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Terlipressin for Injection Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Terlipressin for Injection Consumption Value, 2018-2029
9.3 By Country, Global Terlipressin for Injection Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Terlipressin for Injection Market Size, 2018-2029
9.4.2 By Type, U.S. Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Terlipressin for Injection Market Size, 2018-2029
9.5.2 By Type, Europe Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Terlipressin for Injection Market Size, 2018-2029
9.6.2 By Type, China Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Terlipressin for Injection Market Size, 2018-2029
9.7.2 By Type, Japan Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Terlipressin for Injection Market Size, 2018-2029
9.8.2 By Type, South Korea Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Terlipressin for Injection Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Terlipressin for Injection Market Size, 2018-2029
9.10.2 By Type, India Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Terlipressin for Injection Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Ferring Pharmaceuticals
10.1.1 Ferring Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.1.2 Ferring Pharmaceuticals Terlipressin for Injection Models, Specifications, and Application
10.1.3 Ferring Pharmaceuticals Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Ferring Pharmaceuticals Company Profile and Main Business
10.1.5 Ferring Pharmaceuticals Recent Developments
10.2 Ranbaxy UK Ltd
10.2.1 Ranbaxy UK Ltd Company Information, Head Office, Market Area, and Industry Position
10.2.2 Ranbaxy UK Ltd Terlipressin for Injection Models, Specifications, and Application
10.2.3 Ranbaxy UK Ltd Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Ranbaxy UK Ltd Company Profile and Main Business
10.2.5 Ranbaxy UK Ltd Recent Developments
10.3 TAJ LIFE SCIENCES
10.3.1 TAJ LIFE SCIENCES Company Information, Head Office, Market Area, and Industry Position
10.3.2 TAJ LIFE SCIENCES Terlipressin for Injection Models, Specifications, and Application
10.3.3 TAJ LIFE SCIENCES Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 TAJ LIFE SCIENCES Company Profile and Main Business
10.3.5 TAJ LIFE SCIENCES Recent Developments
10.4 Mallinckrodt plc
10.4.1 Mallinckrodt plc Company Information, Head Office, Market Area, and Industry Position
10.4.2 Mallinckrodt plc Terlipressin for Injection Models, Specifications, and Application
10.4.3 Mallinckrodt plc Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Mallinckrodt plc Company Profile and Main Business
10.4.5 Mallinckrodt plc Recent Developments
10.5 EVER Pharma
10.5.1 EVER Pharma Company Information, Head Office, Market Area, and Industry Position
10.5.2 EVER Pharma Terlipressin for Injection Models, Specifications, and Application
10.5.3 EVER Pharma Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 EVER Pharma Company Profile and Main Business
10.5.5 EVER Pharma Recent Developments
10.6 Alliance Pharmaceuticals
10.6.1 Alliance Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.6.2 Alliance Pharmaceuticals Terlipressin for Injection Models, Specifications, and Application
10.6.3 Alliance Pharmaceuticals Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Alliance Pharmaceuticals Company Profile and Main Business
10.6.5 Alliance Pharmaceuticals Recent Developments
10.7 Serum Institute of India Pvt. Ltd
10.7.1 Serum Institute of India Pvt. Ltd Company Information, Head Office, Market Area, and Industry Position
10.7.2 Serum Institute of India Pvt. Ltd Terlipressin for Injection Models, Specifications, and Application
10.7.3 Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Serum Institute of India Pvt. Ltd Company Profile and Main Business
10.7.5 Serum Institute of India Pvt. Ltd Recent Developments
10.8 Biovenice Criticure
10.8.1 Biovenice Criticure Company Information, Head Office, Market Area, and Industry Position
10.8.2 Biovenice Criticure Terlipressin for Injection Models, Specifications, and Application
10.8.3 Biovenice Criticure Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Biovenice Criticure Company Profile and Main Business
10.8.5 Biovenice Criticure Recent Developments
10.9 Criticine Care
10.9.1 Criticine Care Company Information, Head Office, Market Area, and Industry Position
10.9.2 Criticine Care Terlipressin for Injection Models, Specifications, and Application
10.9.3 Criticine Care Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Criticine Care Company Profile and Main Business
10.9.5 Criticine Care Recent Developments
10.10 Integrated Laboratories Pvt Ltd
10.10.1 Integrated Laboratories Pvt Ltd Company Information, Head Office, Market Area, and Industry Position
10.10.2 Integrated Laboratories Pvt Ltd Terlipressin for Injection Models, Specifications, and Application
10.10.3 Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Integrated Laboratories Pvt Ltd Company Profile and Main Business
10.10.5 Integrated Laboratories Pvt Ltd Recent Developments
10.11 Hybio Pharmaceutical Co., Ltd
10.11.1 Hybio Pharmaceutical Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.11.2 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications, and Application
10.11.3 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Hybio Pharmaceutical Co., Ltd Company Profile and Main Business
10.11.5 Hybio Pharmaceutical Co., Ltd Recent Developments
10.12 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
10.12.1 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.12.2 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications, and Application
10.12.3 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Profile and Main Business
10.12.5 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments
10.13 Hangzhou Ausia Biological Technology Company, Ltd
10.13.1 Hangzhou Ausia Biological Technology Company, Ltd Company Information, Head Office, Market Area, and Industry Position
10.13.2 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Models, Specifications, and Application
10.13.3 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Hangzhou Ausia Biological Technology Company, Ltd Company Profile and Main Business
10.13.5 Hangzhou Ausia Biological Technology Company, Ltd Recent Developments
10.14 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
10.14.1 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.14.2 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Models, Specifications, and Application
10.14.3 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Profile and Main Business
10.14.5 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments
10.15 Hainan General Sanyang Pharmaceutical Co., Ltd
10.15.1 Hainan General Sanyang Pharmaceutical Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.15.2 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications, and Application
10.15.3 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Hainan General Sanyang Pharmaceutical Co., Ltd Company Profile and Main Business
10.15.5 Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Terlipressin for Injection Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Terlipressin for Injection Market Restraints
Table 3. Terlipressin for Injection Market Trends
Table 4. Terlipressin for Injection Industry Policy
Table 5. Global Terlipressin for Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Terlipressin for Injection Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Terlipressin for Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Terlipressin for Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Terlipressin for Injection Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Terlipressin for Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Terlipressin for Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Terlipressin for Injection Manufacturers Product Type
Table 13. Head Office and Terlipressin for Injection Production Site of Key Manufacturer
Table 14. Terlipressin for Injection Capacity of Major Manufacturers and Future Plan
Table 15. China Terlipressin for Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Terlipressin for Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Terlipressin for Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Terlipressin for Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Terlipressin for Injection Production by Region, 2018-2023, (K Units)
Table 20. Global Terlipressin for Injection Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Terlipressin for Injection Upstream (Raw Materials)
Table 22. Global Terlipressin for Injection Typical Customers
Table 23. Terlipressin for Injection Typical Distributors
Table 24. By Type, Global Terlipressin for Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Terlipressin for Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Terlipressin for Injection Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Terlipressin for Injection Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Terlipressin for Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Terlipressin for Injection Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Terlipressin for Injection Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Terlipressin for Injection Sales Quantity Market Share, 2018-2029
Table 34. Ferring Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 35. Ferring Pharmaceuticals Terlipressin for Injection Models, Specifications, and Application
Table 36. Ferring Pharmaceuticals Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Ferring Pharmaceuticals Company Profile and Main Business
Table 38. Ferring Pharmaceuticals Recent Developments
Table 39. Ranbaxy UK Ltd Company Information, Head Office, Market Area, and Industry Position
Table 40. Ranbaxy UK Ltd Terlipressin for Injection Models, Specifications, and Application
Table 41. Ranbaxy UK Ltd Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Ranbaxy UK Ltd Company Profile and Main Business
Table 43. Ranbaxy UK Ltd Recent Developments
Table 44. TAJ LIFE SCIENCES Company Information, Head Office, Market Area, and Industry Position
Table 45. TAJ LIFE SCIENCES Terlipressin for Injection Models, Specifications, and Application
Table 46. TAJ LIFE SCIENCES Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. TAJ LIFE SCIENCES Company Profile and Main Business
Table 48. TAJ LIFE SCIENCES Recent Developments
Table 49. Mallinckrodt plc Company Information, Head Office, Market Area, and Industry Position
Table 50. Mallinckrodt plc Terlipressin for Injection Models, Specifications, and Application
Table 51. Mallinckrodt plc Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Mallinckrodt plc Company Profile and Main Business
Table 53. Mallinckrodt plc Recent Developments
Table 54. EVER Pharma Company Information, Head Office, Market Area, and Industry Position
Table 55. EVER Pharma Terlipressin for Injection Models, Specifications, and Application
Table 56. EVER Pharma Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. EVER Pharma Company Profile and Main Business
Table 58. EVER Pharma Recent Developments
Table 59. Alliance Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 60. Alliance Pharmaceuticals Terlipressin for Injection Models, Specifications, and Application
Table 61. Alliance Pharmaceuticals Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Alliance Pharmaceuticals Company Profile and Main Business
Table 63. Alliance Pharmaceuticals Recent Developments
Table 64. Serum Institute of India Pvt. Ltd Company Information, Head Office, Market Area, and Industry Position
Table 65. Serum Institute of India Pvt. Ltd Terlipressin for Injection Models, Specifications, and Application
Table 66. Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Serum Institute of India Pvt. Ltd Company Profile and Main Business
Table 68. Serum Institute of India Pvt. Ltd Recent Developments
Table 69. Biovenice Criticure Company Information, Head Office, Market Area, and Industry Position
Table 70. Biovenice Criticure Terlipressin for Injection Models, Specifications, and Application
Table 71. Biovenice Criticure Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Biovenice Criticure Company Profile and Main Business
Table 73. Biovenice Criticure Recent Developments
Table 74. Criticine Care Company Information, Head Office, Market Area, and Industry Position
Table 75. Criticine Care Terlipressin for Injection Models, Specifications, and Application
Table 76. Criticine Care Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Criticine Care Company Profile and Main Business
Table 78. Criticine Care Recent Developments
Table 79. Integrated Laboratories Pvt Ltd Company Information, Head Office, Market Area, and Industry Position
Table 80. Integrated Laboratories Pvt Ltd Terlipressin for Injection Models, Specifications, and Application
Table 81. Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Integrated Laboratories Pvt Ltd Company Profile and Main Business
Table 83. Integrated Laboratories Pvt Ltd Recent Developments
Table 84. Hybio Pharmaceutical Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 85. Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications, and Application
Table 86. Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Hybio Pharmaceutical Co., Ltd Company Profile and Main Business
Table 88. Hybio Pharmaceutical Co., Ltd Recent Developments
Table 89. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 90. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications, and Application
Table 91. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Profile and Main Business
Table 93. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments
Table 94. Hangzhou Ausia Biological Technology Company, Ltd Company Information, Head Office, Market Area, and Industry Position
Table 95. Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Models, Specifications, and Application
Table 96. Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Hangzhou Ausia Biological Technology Company, Ltd Company Profile and Main Business
Table 98. Hangzhou Ausia Biological Technology Company, Ltd Recent Developments
Table 99. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 100. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Models, Specifications, and Application
Table 101. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Profile and Main Business
Table 103. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments
Table 104. Hainan General Sanyang Pharmaceutical Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 105. Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications, and Application
Table 106. Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Hainan General Sanyang Pharmaceutical Co., Ltd Company Profile and Main Business
Table 108. Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments
List of Figures
Figure 1. Terlipressin for Injection Picture
Figure 2. Global Terlipressin for Injection Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Terlipressin for Injection Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Terlipressin for Injection Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Terlipressin for Injection Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Terlipressin for Injection Sales Quantity (K Units) & (2018-2029)
Figure 7. China Terlipressin for Injection Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Terlipressin for Injection Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Terlipressin for Injection Market Share of Global, 2018-2029
Figure 10. Global Terlipressin for Injection Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Terlipressin for Injection Key Participants, Market Share, 2022
Figure 12. Global Terlipressin for Injection Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Terlipressin for Injection Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Terlipressin for Injection Production Market Share & Forecast by Region, 2018-2029
Figure 15. Terlipressin for Injection Industry Chain
Figure 16. Terlipressin for Injection Procurement Model
Figure 17. Terlipressin for Injection Sales Model
Figure 18. Terlipressin for Injection Sales Channels, Direct Sales, and Distribution
Figure 19. Lumps
Figure 20. Powder
Figure 21. By Type, Global Terlipressin for Injection Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Terlipressin for Injection Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Terlipressin for Injection Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Terlipressin for Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Internal Medicine Application
Figure 27. surgical application
Figure 28. Intensive Care Unit (ICU) Applications
Figure 29. By Application, Global Terlipressin for Injection Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Terlipressin for Injection Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Terlipressin for Injection Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Terlipressin for Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Terlipressin for Injection Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Terlipressin for Injection Sales Quantity Market Share, 2018-2029
Figure 36. North America Terlipressin for Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Terlipressin for Injection Consumption Value Market Share, 2022
Figure 38. Europe Terlipressin for Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Terlipressin for Injection Consumption Value Market Share, 2022
Figure 40. Asia Pacific Terlipressin for Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Terlipressin for Injection Consumption Value Market Share, 2022
Figure 42. South America Terlipressin for Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Terlipressin for Injection Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Terlipressin for Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Terlipressin for Injection Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Terlipressin for Injection Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|